NeurologyLive® Friday 5 — April 29, 2022

Article

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending April 29, 2022.

Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: AAN Annual Meeting 2022: Top Expert Interviews

This month, the team was on-site in Seattle, Washington, for the 2022 American Academy of Neurology Annual Meeting, providing live coverage of sessions and presentations from the floor of the convention center. While there, the team conducted a variety of sit-down interviews with experts about hot button issues and topics at the annual meeting—these are some of the top conversations.

AAN Annual Meeting 2022: Top Expert Interviews

2: Peer Exchange: Differentiating Migraine From Other Headache Disorders

In Episode 4 of this NeurologyLive® Peer Exchange™, "Optimal Management of Acute and Preventive Migraine," Jessica Ailani, MD, and Bradley Torphy, MD, discern the signs of migraine and comment on the importance of ensuring accurate diagnosis for patients.

Peer Exchange: Differentiating Migraine From Other Headache Disorders

3: NeuroVoices: Mark Lew, MD, on Exploring Reflex Tears as a Biomarker for Parkinson Disease

The director of the Division of Movement Disorders at the University of Southern California Keck School of Medicine discussed the phenomenon behind reflex tears and whether they can serve as a valuable biomarker for Parkinson disease.

NeuroVoices: Mark Lew, MD, on Exploring Reflex Tears as a Biomarker for Parkinson Disease

4: Peers & Perspectives: Managing Narcolepsy Treatment Adherence

In Episode 10 of this NeurologyLive® Peers & Perspectives series, "Improving Diagnosis and Patient Outcomes in Narcolepsy," sleep expert Margaret Park, MD, leads the discussion on setting and managing patient expectations for treatment in narcolepsy.

Peers & Perspectives: Managing Narcolepsy Treatment Adherence

5: The Big Data Revolution’s Role in Developing a Personalized Medicine Model

Shurjal Baxi, MD, MPH, the senior vice president of Clinical and Scientific Solutions at Verana Health, shared her perspective on the American Academy of Neurology’s Axon Registry and how quality data collection can drive improvements in patient care and management.

The Big Data Revolution’s Role in Developing a Personalized Medicine Model

—————————————————

Related Videos
Justin Moy
Diana Castro, MD
Amanda Peltier, MD
Marjan Gharagozloo, PhD
 Jeffrey Huang, PhD
Shiv Saidha, MBBCh
Julie Fiol, MSCN; Andreina Barnola, MD, MPH
© 2024 MJH Life Sciences

All rights reserved.